Life Sciences Capital Markets: Preparing for Your 2026 IPO
The life sciences industry is poised for an upswing in initial public offering (IPO) activity in 2026, supported by a large IPO backlog, the strong performance of biotech market indices, and positive capital markets signals from recent IPOs and secondary …